474 related articles for article (PubMed ID: 35482841)
1. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
Huston JH; Shah SJ
Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension associated with left heart disease.
Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary hypertension associated with left heart disease (group 2)].
Wissmüller M; Tichelbäcker T; Finke K; Dohr J; Adler J; Ochs L; Hohmann C; Baldus S; Rosenkranz S
Dtsch Med Wochenschr; 2023 Nov; 148(23):1498-1506. PubMed ID: 37949078
[TBL] [Abstract][Full Text] [Related]
4. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
van de Veerdonk MC; Roosma L; Trip P; Gopalan D; Vonk Noordegraaf A; Dorfmüller P; Nossent EJ
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38417969
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
Kido K; Coons JC
Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390
[TBL] [Abstract][Full Text] [Related]
6. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C
J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary hypertension – a common condition in left heart disease].
Lundgren J; Rådegran G
Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
[TBL] [Abstract][Full Text] [Related]
11. The Biological Bases of Group 2 Pulmonary Hypertension.
Fernández AI; Yotti R; González-Mansilla A; Mombiela T; Gutiérrez-Ibanes E; Pérez Del Villar C; Navas-Tejedor P; Chazo C; Martínez-Legazpi P; Fernández-Avilés F; Bermejo J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771195
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular heart failure and pulmonary hypertension.
Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
[TBL] [Abstract][Full Text] [Related]
13. Animal models of pulmonary hypertension due to left heart disease.
Liu SF; Yan Y
Animal Model Exp Med; 2022 Sep; 5(3):197-206. PubMed ID: 35234367
[TBL] [Abstract][Full Text] [Related]
14. Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction.
Segovia F; Garcia H; Alkhateeb H; Mukherjee D; Nickel N
Cardiovasc Hematol Disord Drug Targets; 2023; 23(4):215-225. PubMed ID: 37921162
[TBL] [Abstract][Full Text] [Related]
15. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
[TBL] [Abstract][Full Text] [Related]
16. Management of Pulmonary Hypertension in Left Heart Disease.
Macera F; Vachiéry JL
Methodist Debakey Cardiovasc J; 2021; 17(2):115-123. PubMed ID: 34326931
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.
Hunt JM; Bethea B; Liu X; Gandjeva A; Mammen PP; Stacher E; Gandjeva MR; Parish E; Perez M; Smith L; Graham BB; Kuebler WM; Tuder RM
Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L725-36. PubMed ID: 24039255
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of pulmonary hypertension caused by left heart disease.
Xiao M; Lai D; Yu Y; Wu Q; Zhang C
Front Cardiovasc Med; 2023; 10():1079142. PubMed ID: 36937903
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension associated with left heart disease.
Adir Y; Amir O
Semin Respir Crit Care Med; 2013 Oct; 34(5):665-80. PubMed ID: 24037633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]